
Sign up to save your podcasts
Or


Antibiotic resistance is a global problem but there have been no new drugs produced since the 1980s. So who is to blame? The public's over-consumption or the current economic model for drug research and production? Evan Davis and guests discuss.
GUESTS
Seema Patel, Medical Director, Hospital Business, Pfizer, UK, Ireland and the Nordics
Lord Jim O'Neill, Chair Anti-Microbial Resistance Review (2016), Former Chief Economist, Goldman Sachs
Professor Colin Garner, Co Founder and Director, Antibiotic Research UK
By BBC Radio 44.7
3232 ratings
Antibiotic resistance is a global problem but there have been no new drugs produced since the 1980s. So who is to blame? The public's over-consumption or the current economic model for drug research and production? Evan Davis and guests discuss.
GUESTS
Seema Patel, Medical Director, Hospital Business, Pfizer, UK, Ireland and the Nordics
Lord Jim O'Neill, Chair Anti-Microbial Resistance Review (2016), Former Chief Economist, Goldman Sachs
Professor Colin Garner, Co Founder and Director, Antibiotic Research UK

7,640 Listeners

379 Listeners

893 Listeners

1,062 Listeners

57 Listeners

36 Listeners

5,475 Listeners

1,802 Listeners

1,747 Listeners

1,045 Listeners

2,115 Listeners

2,087 Listeners

756 Listeners

69 Listeners

236 Listeners

74 Listeners

98 Listeners

624 Listeners

127 Listeners

3,202 Listeners

1,605 Listeners

2,906 Listeners

775 Listeners

176 Listeners

51 Listeners